Éric Chabrière

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · medRxiv · 2020 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

Matthieu Million, Jean‐Christophe Lagier, Philippe Gautret et al. · Travel Medicine and Infectious Disease · 2020 · 489 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis

Jean‐Christophe Lagier, Matthieu Million, Philippe Gautret et al. · Travel Medicine and Infectious Disease · 2020 · 264 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

The molecular basis of phosphate discrimination in arsenate-rich environments

Mikael Elias, Alon Wellner, Korina Goldin-Azulay et al. · Nature · 2012 · 220 citations

Natural Sciences, Biochemistry, Chemistry +16